| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | MYLAN N V | 800,000 | 47,480,000 | 2.27% | Call | |
| 52 | MEDIVATION INC | 375,000 | 48,401,000 | 2.31% | ||
| 53 | TESARO INCORPORATED | 925,000 | 53,095,000 | 2.53% | ||
| 54 | JAZZ PHARMACEUTICALS PLC | 325,000 | 56,157,000 | 2.68% | ||
| 55 | MYLAN N V | 1,146,400 | 68,039,000 | 3.25% | ||
| 56 | PFIZER INC | 2,000,000 | 69,580,000 | 3.32% | Call | |
| 57 | TEVA PHARMACEUTICAL INDS LTD | 1,150,000 | 71,645,000 | 3.42% | ||
| 58 | BROOKDALE SR LIVING INC | 1,950,000 | 73,632,000 | 3.51% | ||
| 59 | AETNA INC NEW | 700,000 | 74,571,000 | 3.56% | ||
| 60 | AGILENT TECHNOLOGIES INC | 1,825,000 | 75,829,000 | 3.62% | Call | |
| 61 | BIOGEN INC | 190,700 | 80,521,000 | 3.84% | ||
| 62 | LABORATORY CORP AMER HLDGS | 675,000 | 85,111,000 | 4.06% | ||
| 63 | GILEAD SCIENCES INC | 1,000,000 | 98,130,000 | 4.68% | Call | |
| 64 | MALLINCKRODT PUB LTD CO | 800,000 | 101,320,000 | 4.83% | ||
| 65 | HORIZON PHARMA PLC | 4,000,000 | 103,880,000 | 4.96% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001343781-15-000004, filed 2015.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
